The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antimicrobial Peptides Market Research Report 2024
Synopsis
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The global Antimicrobial Peptides market was valued at US$ 5 million in 2023 and is anticipated to reach US$ 7 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Peptides.
Report Scope
The Antimicrobial Peptides market size, estimations, and forecasts are provided in terms of sales volume (Mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antimicrobial Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobial Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Segment by Application
Pharmaceuticals
Feed Additives
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antimicrobial Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The global Antimicrobial Peptides market was valued at US$ 5 million in 2023 and is anticipated to reach US$ 7 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Peptides.
Report Scope
The Antimicrobial Peptides market size, estimations, and forecasts are provided in terms of sales volume (Mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antimicrobial Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobial Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Segment by Application
Pharmaceuticals
Feed Additives
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antimicrobial Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antimicrobial Peptides Market Overview
1.1 Product Overview and Scope of Antimicrobial Peptides
1.2 Antimicrobial Peptides Segment by Type
1.2.1 Global Antimicrobial Peptides Market Value Comparison by Type (2024-2030)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Antimicrobial Peptides Segment by Application
1.3.1 Global Antimicrobial Peptides Market Value by Application: (2024-2030)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Global Antimicrobial Peptides Market Size Estimates and Forecasts
1.4.1 Global Antimicrobial Peptides Revenue 2019-2030
1.4.2 Global Antimicrobial Peptides Sales 2019-2030
1.4.3 Global Antimicrobial Peptides Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antimicrobial Peptides Market Competition by Manufacturers
2.1 Global Antimicrobial Peptides Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antimicrobial Peptides Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antimicrobial Peptides Average Price by Manufacturers (2019-2024)
2.4 Global Antimicrobial Peptides Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antimicrobial Peptides, Product Type & Application
2.7 Antimicrobial Peptides Market Competitive Situation and Trends
2.7.1 Antimicrobial Peptides Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antimicrobial Peptides Players Market Share by Revenue
2.7.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antimicrobial Peptides Retrospective Market Scenario by Region
3.1 Global Antimicrobial Peptides Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antimicrobial Peptides Global Antimicrobial Peptides Sales by Region: 2019-2030
3.2.1 Global Antimicrobial Peptides Sales by Region: 2019-2024
3.2.2 Global Antimicrobial Peptides Sales by Region: 2025-2030
3.3 Global Antimicrobial Peptides Global Antimicrobial Peptides Revenue by Region: 2019-2030
3.3.1 Global Antimicrobial Peptides Revenue by Region: 2019-2024
3.3.2 Global Antimicrobial Peptides Revenue by Region: 2025-2030
3.4 North America Antimicrobial Peptides Market Facts & Figures by Country
3.4.1 North America Antimicrobial Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antimicrobial Peptides Sales by Country (2019-2030)
3.4.3 North America Antimicrobial Peptides Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antimicrobial Peptides Market Facts & Figures by Country
3.5.1 Europe Antimicrobial Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antimicrobial Peptides Sales by Country (2019-2030)
3.5.3 Europe Antimicrobial Peptides Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antimicrobial Peptides Market Facts & Figures by Country
3.6.1 Asia Pacific Antimicrobial Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antimicrobial Peptides Sales by Country (2019-2030)
3.6.3 Asia Pacific Antimicrobial Peptides Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antimicrobial Peptides Market Facts & Figures by Country
3.7.1 Latin America Antimicrobial Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antimicrobial Peptides Sales by Country (2019-2030)
3.7.3 Latin America Antimicrobial Peptides Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antimicrobial Peptides Market Facts & Figures by Country
3.8.1 Middle East and Africa Antimicrobial Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antimicrobial Peptides Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antimicrobial Peptides Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antimicrobial Peptides Sales by Type (2019-2030)
4.1.1 Global Antimicrobial Peptides Sales by Type (2019-2024)
4.1.2 Global Antimicrobial Peptides Sales by Type (2025-2030)
4.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2019-2030)
4.2 Global Antimicrobial Peptides Revenue by Type (2019-2030)
4.2.1 Global Antimicrobial Peptides Revenue by Type (2019-2024)
4.2.2 Global Antimicrobial Peptides Revenue by Type (2025-2030)
4.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2019-2030)
4.3 Global Antimicrobial Peptides Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antimicrobial Peptides Sales by Application (2019-2030)
5.1.1 Global Antimicrobial Peptides Sales by Application (2019-2024)
5.1.2 Global Antimicrobial Peptides Sales by Application (2025-2030)
5.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2019-2030)
5.2 Global Antimicrobial Peptides Revenue by Application (2019-2030)
5.2.1 Global Antimicrobial Peptides Revenue by Application (2019-2024)
5.2.2 Global Antimicrobial Peptides Revenue by Application (2025-2030)
5.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2019-2030)
5.3 Global Antimicrobial Peptides Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AnaSpec
6.1.1 AnaSpec Corporation Information
6.1.2 AnaSpec Description and Business Overview
6.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AnaSpec Antimicrobial Peptides Product Portfolio
6.1.5 AnaSpec Recent Developments/Updates
6.2 AMP Biotech
6.2.1 AMP Biotech Corporation Information
6.2.2 AMP Biotech Description and Business Overview
6.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AMP Biotech Antimicrobial Peptides Product Portfolio
6.2.5 AMP Biotech Recent Developments/Updates
6.3 Phoenix Biotech
6.3.1 Phoenix Biotech Corporation Information
6.3.2 Phoenix Biotech Description and Business Overview
6.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Phoenix Biotech Antimicrobial Peptides Product Portfolio
6.3.5 Phoenix Biotech Recent Developments/Updates
6.4 Novabiotics
6.4.1 Novabiotics Corporation Information
6.4.2 Novabiotics Description and Business Overview
6.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novabiotics Antimicrobial Peptides Product Portfolio
6.4.5 Novabiotics Recent Developments/Updates
6.5 Chinese Peptide
6.5.1 Chinese Peptide Corporation Information
6.5.2 Chinese Peptide Description and Business Overview
6.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chinese Peptide Antimicrobial Peptides Product Portfolio
6.5.5 Chinese Peptide Recent Developments/Updates
6.6 Ontores
6.6.1 Ontores Corporation Information
6.6.2 Ontores Description and Business Overview
6.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ontores Antimicrobial Peptides Product Portfolio
6.6.5 Ontores Recent Developments/Updates
6.7 GenScript
6.6.1 GenScript Corporation Information
6.6.2 GenScript Description and Business Overview
6.6.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GenScript Antimicrobial Peptides Product Portfolio
6.7.5 GenScript Recent Developments/Updates
6.8 Hycult Biotech
6.8.1 Hycult Biotech Corporation Information
6.8.2 Hycult Biotech Description and Business Overview
6.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hycult Biotech Antimicrobial Peptides Product Portfolio
6.8.5 Hycult Biotech Recent Developments/Updates
6.9 Sunsmile
6.9.1 Sunsmile Corporation Information
6.9.2 Sunsmile Description and Business Overview
6.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sunsmile Antimicrobial Peptides Product Portfolio
6.9.5 Sunsmile Recent Developments/Updates
6.10 Ruixing Biotechnology
6.10.1 Ruixing Biotechnology Corporation Information
6.10.2 Ruixing Biotechnology Description and Business Overview
6.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Portfolio
6.10.5 Ruixing Biotechnology Recent Developments/Updates
6.11 Zhongnong Yingtai Biotechnology
6.11.1 Zhongnong Yingtai Biotechnology Corporation Information
6.11.2 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Description and Business Overview
6.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio
6.11.5 Zhongnong Yingtai Biotechnology Recent Developments/Updates
6.12 Glam Technology
6.12.1 Glam Technology Corporation Information
6.12.2 Glam Technology Antimicrobial Peptides Description and Business Overview
6.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Glam Technology Antimicrobial Peptides Product Portfolio
6.12.5 Glam Technology Recent Developments/Updates
6.13 ProteLight Pharmaceutical & Biotechnology
6.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
6.13.2 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Description and Business Overview
6.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio
6.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antimicrobial Peptides Industry Chain Analysis
7.2 Antimicrobial Peptides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antimicrobial Peptides Production Mode & Process
7.4 Antimicrobial Peptides Sales and Marketing
7.4.1 Antimicrobial Peptides Sales Channels
7.4.2 Antimicrobial Peptides Distributors
7.5 Antimicrobial Peptides Customers
8 Antimicrobial Peptides Market Dynamics
8.1 Antimicrobial Peptides Industry Trends
8.2 Antimicrobial Peptides Market Drivers
8.3 Antimicrobial Peptides Market Challenges
8.4 Antimicrobial Peptides Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
